1 / 5

Winson Tang MD Clinical Research

Winson Tang MD with years of experience as a nephrologist, scientist and clinical researcher was made the Chief Operating Officer of Xcorporeal Inc., in 2007. Dr. Tang was responsible for the daily operation of the company when it completed a functional prototype of its first device, a portable home hemodialysis machine.

winsontangmd
Download Presentation

Winson Tang MD Clinical Research

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Winson Tang MD Clinical Research As the Vice President of Clinical Research for Sangamo Bioscience, Inc., located in Richmond, CA, Winson Tang MD is responsible for all clinical research programs within the company. These include CAR T-cells for glioblastoma, HIV cell therapy, and diabetic neuropathy. Sangamo is a clinical stage development company that specializes in the use of Zinc Finger Proteins for gene and cell therapy.

  2. Winson Tang MD Medical Consultant Between Nov. 2008 and Dec. 2009, Winson Tang MD worked as a Medical Consultant for Amsterdam Molecular Therapeutics in Amsterdam, The Netherlands. He was responsible for the conduct of Phase 2/3 Glybera orphan drug registration trial for lipoprotein lipase deficiency. He was also instrumental in the development of the Glybera product profile. The MAA for Glybera was submitted to the EMA in Dec 2009. It is the first and remains the only gene therapy product approved in the western world.

  3. Winson Tang MD Leadership Ability When the financial crisis of 2008-09 hit, Winson Tang MD was working as the Director of Life Science for the Pacific Capital Group. During this time, a lack of interest in healthcare investments saw Dr. Tang move to Xcorporeal Inc., as its Chief Operating Officer responsible for daily operations. The company developed a prototype of a portable home hemodialysis machine and was working on a Wearable Artificial Kidney when it was acquired by Fresenius AG.

  4. Winson Tang MD Drug Development Winson Tang MD is a Board certified and experienced physician, clinical researcher and scientist who has worked on the drug development side of the biotechnology industry. He has worked at a number of companies including Amgen, Tularik, Isis and Sangamo BioSciences. As a consultant to Amsterdam Molecular Therapeutics, he oversaw the conduct of the registration trial of Glybera for lipoprotein lipase deficiency. Glybera was subsequently approved for marketing by the EMA and remains the only gene therapy product approved in the western world.

  5. THANK YOU... For more details visit at : http://winsontangmd.tumblr.com/ https://twitter.com/winsontangmd https://www.behance.net/winsontangmd https://medium.com/@winsontangmd

More Related